BYG MED THEILL IVS: Financial statements 2020
CVR: 36023848
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
BYG MED THEILL IVS (CVR 36023848) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK 0.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | 0 | 0 | 0 | - |
| 2019 | 0 | 0 | 0 | 0 | - |
| 2018 | 0 | 0 | 0 | 0 | - |
| 2017 | 0 | 0 | 0 | 0 | - |
| 2016 | 0 | 0 | 0 | 0 | - |
Official annual report
How creditworthy is BYG MED THEILL IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BYG MED THEILL IVS has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK 0.
About BYG MED THEILL IVS
BYG MED THEILL IVS was a Danish company of the type Iværksætterselskab based in Tommerup, founded in 2014. The company has been dissolved on 21 April 2022. The company was registered under the industry Murere. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK 0.
